|4Jun 16, 8:02 PM ET

Doberstein Stephen K 4

4 · Dicerna Pharmaceuticals Inc · Filed Jun 16, 2020

Insider Transaction Report

Form 4
Period: 2020-06-15
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2020-06-15+15,00015,000 total
    Exercise: $21.61Exp: 2030-06-14Common Stock (15,000 underlying)
  • Award

    Restricted Stock Units

    2020-06-15+3,3333,333 total
    Common Stock (3,333 underlying)
Footnotes (2)
  • [F1]Represents restricted stock units ("RSUs") that vest 12 months from June 15, 2020 ("Grant Date"), provided that these RSUs vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through such vesting date or, if earlier, such annual meeting. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock.
  • [F2]This option vests monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the option vests in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Documents

2 files